Why Tell Children: A Synthesis of the Global Literature on Reasons for Disclosing or Not Disclosing an HIV Diagnosis to Children 12 and under
- 1School of Public Health, City University of New York, New York, NY, USA
- 2Department of Social Work, York College, City University of New York, New York, NY, USA
- 3Public Health Initiative Consultant, Lagos, Nigeria (formerly affiliated with Rogosin Institute, New York, NY, USA)
While the psychological and health benefits of knowing one’s HIV diagnosis have been documented for adults and adolescents, practice is still in development for younger children. Moderating conditions for whether or not to tell a child he/she has HIV vary by region and local context. They include accessibility of treatment, consideration of HIV as a stigmatizing condition, prevalence of HIV, and an accompanying presumption that any illness is HIV-related, parent or caregiver concerns about child reactions, child’s worsening health, assumptions about childhood and child readiness to know a diagnosis, and lack of policies such as those that would prevent bullying of affected children in schools. In this systematic review of the global literature, we summarize the reasons caregivers give for telling or not telling children 12 and under their HIV diagnosis. We also include articles in which children reflect on their desires for being told. While a broad number of reasons are given for telling a child – e.g., to aid in prevention, adaptation to illness (e.g., primarily to promote treatment adherence), understanding social reactions, and maintaining the child–adult relationship – a narrower range of reasons, often related to immediate child or caregiver well-being or discomfort, are given for not telling. Recommendations are made to improve the context for disclosure by providing supports before, during, and after disclosure and to advance the research agenda by broadening samples and refining approaches.
In countries spread across the globe, mothers, fathers, grandparents, aunts, uncles, sisters, brothers, and foster parents must face telling one or more of the children in their care that the children have a diagnosis of HIV. Their disclosures often occur against a backdrop of multiple family losses (1–3), and in families and communities where not everyone is accepting of those with HIV (4–6). Caregivers may face the disclosure process alone, have the assistance of health-care providers, delegate the task to providers, or be pre-empted by health systems or inadvertent disclosure (e.g., community gossip, visible records, overheard conversations) (7–9). Caregivers face multiple issues during disclosure, anticipated by those with experience with children and with global health issues.
In the opening paragraph of their 1999 recommendations for disclosure of HIV/AIDS diagnoses to children, the American Academy of Pediatrics (AAP) Committee on Pediatric AIDS [(10), p. 164] succinctly states, “Disclosure of HIV infection status to children and adolescents should take into consideration their age, psychosocial maturity, the complexity of family dynamics, and the clinical context.” The World Health Organization [WHO (11), p. 12] in its 2011 guidance on disclosure to children 12 and under provided greater specificity – “children of school age should be told their HIV-positive status; younger children should be told their status incrementally to accommodate their cognitive skills and emotional maturity, in preparation for full disclosure.” The guidance also broadened the AAP statement to include the community context – schools, institutions, and local and national laws and policies. The broader context was deemed important so that disclosure could be addressed in a culturally sensitive manner, and so that laws, policies, and institutional or community cultures that may be damaging (e.g., lack protections against stigmatization of those with HIV) could be changed to foster the well-being of HIV+ children and their caregivers (10). Both the AAP and WHO documents describe disclosure as a process rather than a single event, suggest that HIV+ children’s caregivers may need to be supported in the disclosure process, and underline the well-being of affected children as a fundamental guide to disclosure decision-making.
Several clinicians, researchers, and reviews have suggested that knowing their HIV diagnosis in a timely manner enhances children’s cooperation with antiretroviral therapy (ART) (11–14), helps children understand their illness and promotes self-care (15), relieves a burden of secrecy within families (5), prepares children to protect others as they approach the teen years which often include greater sexual and drug transmission risks (16), and, fundamentally, is a right as children mature (4, 8, 17). Risks of disclosure to children have also been noted (14), but these appear outweighed by benefits (18).
Although progress has been made in reducing HIV prevalence among children, especially in preventing mother to child transmission during pregnancy, childbirth, and through breastfeeding, timely disclosure to HIV+ children remains a concern. At the end of 2014, an estimated 2.6 million children under age 15 were living with HIV worldwide, the majority in low and middle income countries, an estimated 85% in 21 sub-Saharan countries and India. There were approximately 220,000 new infections that year; and only an estimated 32% of children living with HIV or AIDS were accessing ART, much lower than the figures for the adolescent/adult population (10, 19). Worldwide a minority of HIV+ children 12 and under (<5%) have acquired HIV through blood transfusion, needle sticks, sex (sexual abuse, early sexual debut, or sex trafficking), or injected drug use (20); the majority acquired HIV through mother to child transmission (20).
Researchers and clinicians have worked to translate the general guidance for disclosure to children into workable and context-sensitive interventions [e.g., Ref. (3, 9, 21–23)]. However, in the literature to date, it is most often the primary caregiver, with or without assistance from health care workers, who actually discloses to the HIV+ children in their care. In fact, many interventions to aid disclosure, recently developed or under development, begin with interviews of caregivers about the issues facing them around disclosure. The current review synthesizes articles published about caregivers worldwide as they reflect on the reasons they have or have not disclosed to HIV+ children. In Section “Discussion,” the review is expanded by including articles, which summarize the viewpoints of health-care personnel and articles summarizing the reflections of HIV+ children subsequent to their disclosure experiences. Finally, recommendations are made for improving research and practice for disclosure to children 12 and under.
Definition of Disclosure
In 1997, Funck-Brentano et al. (24) proposed patterns of disclosure: (1) full disclosure in which HIV is named as the diagnosis, (2) partial disclosure in which factual discussions are held about symptoms, treatments, and immunodeficiency, and (3) two forms of non-disclosure – avoidance/delay and misnaming of the illness. In our review, we are defining disclosure as full disclosure, thus limiting the number of articles eligible for inclusion.
Eligibility of Articles
To be included, articles needed to focus on issues regarding disclosure of children’s HIV status to HIV+ children 12 and under. Articles were included if some, but not all, children met the age criteria, i.e., if an article concerned 10–18 year olds. Since ART has had a profound effect on the conception of HIV as a treatable illness, articles prior to 1996, considered the benchmark year for the introduction of ART (21), were excluded. Articles published through December 2015 were included. A subset of eligible articles was entered into a database concerning caregivers’ rationales for disclosing or not disclosing. The remaining articles served as background material to enhance discussion of the database summary and of recommendations concerning disclosure research and practice.
Eligibility for Inclusion in a Database of Disclosure Rationales
To be included in a database summarizing the reasons caregivers gave for fully disclosing or not fully disclosing, the caregivers had to be discussing an actual, rather than hypothetical, disclosure situation. That is, their descriptions were focused on the child/children they were caring for and why they had or had not told the child his or her HIV status. General discussions about how caregivers ought to behave, what respondents thought guided caregivers in general, or what caregivers said they might do in the future were excluded from the database.
A search of the 60 international databases of the academic arm of EBSCO1 was made using the terms (HIV or AIDS), (disclosure or telling or diagnosis), and (children or adolescents) from January 1996 through December 2015. The search was repeated with the additional terms (reason or rationale or influenc* or decision or factor). Results of the search were checked and expanded by a hand search of references in review articles and by a search of references in key articles. The current search replicated a search conducted by two health librarians, two senior researchers (the first and second authors of the current manuscript) and two research assistants summarizing literature through June 30, 2010 for the WHO guidance on disclosure (18). However, the current search was limited to disclosure of the child’s own HIV status, limited to the post-ART era, and extended to the end of 2015. The current search was conducted by the first and third authors and checked by the second author through hand search of references in key articles and reviews.
Abstracts and Method sections were read to ascertain eligibility. Full text copies of all eligible articles, save one, were obtained. The remaining article was read on-line as full text. Two articles were translated into English from Spanish and from Portuguese sources; the remaining full texts were in English.
All eligible articles were read in full and then summarized, with a subset of articles read by two to three of the authors to confirm the accuracy of the summaries. An Excel database was created for the 18 articles concerning caregivers’ rationales for full disclosure or non-disclosure. It included the source of the sample, data sources (e.g., interview, questionnaire), country in which the research was conducted, descriptors of the total child sample, descriptors of the children told and the caregivers who told, rationales for telling and not telling, additional predictors of disclosure, and notes about special concerns regarding the context or the data. As rationales were accrued, higher order categorizations were made, e.g., reasons related to the child’s illness, to the parent–child relationship. Categories and higher order categories were cataloged in the database. Disagreements between the author/analysts were noted and were resolved by discussion.
The full complement of search terms yielded 5,099 articles, the vast majority of which were irrelevant, e.g., hearing “aids.” Removal of articles focused solely on the clinical picture of HIV/AIDS in a pediatric population or treatment of pediatric HIV, disclosure of parental HIV, disclosure in serodiscordant couples, disclosure to family and friends by older youth and adolescents, and disclosure for illnesses other than HIV infection also greatly reduced the number of articles. Of the remaining 147 articles, seven were removed as ineligible (three, although published after January 1, 1996, concerned HIV+ children pre-ART; one was available only as a conference abstract; one concerned HIV+ children above the age range; and one focused solely on the prevalence of mental health issues among HIV+ children with disclosure mentioned as a potential correlate of adjustment). Hand search of the reference sections of review and key articles yielded five additional articles. Thus, the total sample consisted of 145 articles pertinent to disclosure to children with HIV.
Articles Concerning Caregivers’ Reasons for Fully Disclosing or Not Disclosing
Of these 145 articles, 18 (22, 23, 25–40) were selected as meeting inclusion criteria for this review. Listed in Table 1, articles concerned (1) caregivers’ rationales for fully disclosing and not disclosing children’s HIV status to the children and (2) included HIV+ children 12 and under. Five discussed only reasons for non-disclosure (22, 29, 31, 37, 40); 3 documented only reasons for full disclosure (25, 38, 39); and the remaining 10 covered both full disclosure and non-disclosure (23, 26–28, 30, 32–36). Data originated from 11 countries: 9 of the 22 United Nations priority countries (10) for the elimination of childhood HIV [Democratic Republic of the Congo (DRC), Ethiopia, Ghana, India, Kenya, Nigeria, South Africa, Uganda, and Zambia], and Thailand and the United States of America (USA). Nearly all data were collected from urban, regional, or district hospitals and clinics or networks of clinics through face-to-face interview, or structured, and semi-structured interviews of caregivers, with one study collecting sealed confidential surveys (29). Two investigators (31, 34) purposively collected rural samples. In 7 of the 18 articles, HIV+ children or older youth aware of their status also provided data (26, 28, 30, 35, 38–40).
Table 1. Characteristics of articles 1996–2015 describing caregivers’ reasons for telling or not telling children in their care the children’s HIV diagnoses.
Reasons for Full Disclosure
Reasons that caregivers gave for telling their child(ren) are summarized in Table 2. Thirteen articles examined their reasons for full disclosure (23, 25–28, 30, 32–36, 38, 39). Since these articles varied in whether or not they calculated the frequency with which caregivers used these reasons, the reasons are tabulated according to the number and percentage of articles in which they appeared in tables or text. Heading the list was the “child’s questions or curiosity” (mentioned in 69.2% of the articles). This rationale was followed by “improve adherence” (61.5%), “child age/maturity” (46.2%), “be the one to tell” (46.2%), and “assist child to reduce risks to self and others” (46.2%). Seven additional rationales were, in order of frequency: “child’s right to know” (38.5% of articles), “promote self-care and general health” (38.5%), “keep an honest relationship” (30.8%), “explain disease progression and/or symptoms” (30.8%), “start medication” (15.4%), “explain discrimination” (15.4%), and prepare the child for the disclosure of other’s HIV status, e.g., the status of relatives or friends (7.7%). With the exception of the last two rationales, reasons were distributed across multiple countries. Thus, the rationales appeared to concern maintaining an open parent–child relationship, recognizing the child’s needs and rights, and enlisting the child’s cooperation in promoting health and protecting others.
Table 2. Number of articles citing the specific reasons caregivers offer for disclosing a child’s HIV status to the child.
Who Is Told, When, and by Whom
The 13 studies documenting full disclosure together covered children in the age range of 4–18 years old. The disclosure rate was 31.0% across the 11 (23, 25–28, 31–36) studies for which it could be calculated; less than a third of the 1,168 HIV+ children and youth sampled had been told their diagnosis. The rate varied from a low of 13.5% in a relatively large Nigerian study (27) to a high of 56.7% in a small Zambian study (34).
Calculating across the 12 studies where the mean or median age at disclosure was reported or could be calculated (23, 25–27, 31–36, 38, 39), on average HIV+ children were 10.6 when told their diagnosis. Mean age varied from a low of 8.7 to a high of 15.0 across studies. Many studies did not include measures of range or variability, so it is difficult to infer the youngest and oldest ages at disclosure.
Caregivers were described with varying degrees of specificity (e.g., parent vs. mother or father) study to study. Table 3 suggests that a significant minority of caregivers were grandparents and other relatives and that health-care personnel had taken on an important role in disclosure. Further, at least three studies (32, 36, 38) documented that children may learn about their HIV status inadvertently or by inference (e.g., looking at their medical records, overhearing discussions, or inferring from HIV public service announcements or talk among school friends).
Reasons for Not Disclosing
Table 4 summarizes the reasons that caregivers gave for not telling their child(ren). Fifteen articles (22, 23, 26–37, 40) discussed these reasons. The most prevalent reasons were “anticipation of the child’s negative psychological reaction” (mentioned in 93.3% of the articles). This rationale was followed by “the child is too young to understand” (86.7%), “the child is unable to keep a secret” (66.7%), “potential social rejection of the child” (60.0%), and “the parent fears anger/blame from the child” (53.3%). Five additional rationales were, in order of frequency: “caregiver feels he/she lacks the skills to communicate HIV status to the child” (40.0% of articles), “parent fears shame/guilt” (20.0%), “parent fears rejection by the child” (20.0%), “parent fears child may reject drugs” (20.0%), and “parent fears questions from the child” (13.3%). The rationales appear to concern potential sociopsychological harm to the child or the family with only one rationale focused on managing the illness.
Table 4. Number of articles citing the specific reasons caregivers offer for not disclosing a child’s HIV status to the child.
Correlates of Full Disclosure
It should be noted that for studies that assessed correlates/predictors of full disclosure rarely did the fact that the child was male or female or parent characteristics have an influence. More frequently, significant correlates were related to the child’s illness and health. These included non-perinatal mode of transmission (25); the relative health of the child (feeling well, having hospitalizations, having new symptoms or suddenly worsening health) (35, 36, 40); other health transitions (e.g., starting ART) (25, 33, 40); and experience managing the illness (e.g., longer duration of illness, longer time on ART, self-administration of medicines) (25, 30). Child social and intellectual factors included life transitions (e.g., enrolling in school) (25, 33), and signs of cognitive maturity (being in school, being more educated, higher IQ) (30, 32, 33). For caregivers, both higher (25) and lower education (35) have been associated with disclosure. Disclosure of either the caregiver’s HIV status to the child or the child’s HIV status to other family members (23, 37) have been cited as promoting disclosure. Family communication factors have also been significantly associated with disclosure: children’s persistence in asking questions about their illness (33) and a family environment that encourages the direct expression of feelings (32). Only the presence of the biological father seems to be associated with lower disclosure (30, 33, 36).
Eighteen articles, January 1996 through December 2015, cataloged caregiver’s rationales for fully disclosing or not disclosing children’s HIV status to children 12 and under post-ART. The studies covered an age range for children from 4 to 18, and across 11 countries, including 9 targeted by the United Nations for the elimination of childhood HIV, documented an average rate of disclosure of 31%. On average, HIV+ children who were told were over 10, well beyond the recommendation to tell school-age children (primary school starting ages are typically 5–7 worldwide according to World Bank Data2) or the age of assent, 7 years old, for children in clinical trials (18, 41, 42). Indeed some studies did not include children in lower age ranges [e.g., Ref. (32, 39)] restricting the range for mean age of disclosure. A few children learned their HIV status inadvertently; a significant minority was told by grandparents, other relatives or by health-care providers; an apparent majority were told by biological parents.
Although data were gathered principally from urban treatment centers, 69% of the more than 1,100 children and youth in these studies had not learned their HIV status.
Across articles, caregivers cited reasons for disclosing that emphasized the child’s needs (the child’s questions or curiosity, child’s age/maturity, child’s right to know, explain discrimination), maintenance of an open caregiver–child relationship (be the one to tell, keep an honest relationship, prepare the child for the disclosure of others’ HIV), and enlisted the child’s cooperation in promoting health and protecting others (improve adherence, assist child to reduce risks to self and others, promote self-care and general health, explain disease progression and/or symptoms, start medication) (23, 25–28, 30, 32–36, 38, 39). In addition, external events, such as enrollment in school (25, 33) or admission to the hospital (35, 36, 40), were cited as motivating disclosure.
Reasons for not disclosing concerned fears about potential sociopsychological harm to the child (anticipation of the child’s negative psychological reaction, child is too young to understand, potential social rejection of the child) or to the family (child is unable to keep a secret, parent fears anger/blame from the child, caregiver feels he/she lacks the skills to communicate HIV status to the child, parent fears shame/guilt, parent fears rejection by the child, parent/caregiver fears questions from the child) (22, 23, 26–37, 40) with one rationale focused on managing the illness (caregiver fears child may reject drugs) (27).
Some of these fears have merit as documented by a number of studies. Children’s initial reactions of sadness, worry, confusion, and shock have been described (36, 39, 43), as have instances of discrimination and bullying at school and in communities (1, 8, 44). Caregivers and even health-care providers may lack the knowledge and skills to effectively communicate an HIV diagnosis to the child (45), and some of this may be due to HIV+ caregivers’ own negative disclosure experiences (3).
However, an even broader literature indicates that children’s initial reactions dissipate relatively quickly over time (43, 46) and may be overestimated by caregivers, especially caregivers who themselves have issues of anxiety or depression (35, 47). At least one study, interviewing children, reported that disclosure was not associated with more negative psychological outcomes (40). Knowing one’s HIV status does appear to be associated with stable or improved child well-being (18, 48) and disease management (11–13). Children, themselves, reflecting on disclosure often mention a sense of relief, wishing that disclosure had happened earlier, that their questions had been answered more directly and that more support had been available initially and subsequently in the family, community, and health-care setting (33, 39, 45, 49, 50). In some studies, children also described their own improved adherence (28, 40).
Regarding discrimination, the literature seems to suggest intervention at the local, institutional, and national policy level. It is not only children with HIV who experience teasing and bullying – often especially upsetting to children because of pervasive messages about sexual transmission – but those presumed to have HIV because of a rash, an illness, a family illness, slight stature, or geographic location of high HIV prevalence, whether indeed they have HIV or not (1, 6, 44).
Include a Broader Set of Populations
In the search for articles worldwide that focused on caregiver reasons for disclosure to children, only 9 of the 22 high priority countries for the elimination of childhood HIV were represented (10). Missing from the 18 articles found were the remaining 13 countries: Angola, Botswana, Burundi, Cameroon, Chad, Cote d’Ivoire, Lesotho, Malawi, Mozambique, Namibia, Swaziland, United Republic of Tanzania, and Zimbabwe. Thus, we do not know if the limited set of rationales, documented here and relatively stable across the countries studied, would also hold for the remaining highly affected countries.
Samples were almost always drawn from urban treatment centers. Many excluded orphans or children at boarding schools. Almost all focused exclusively on perinatally infected children and youth. Thus, our picture of disclosure to children would be enhanced by looking at rural, out-of-treatment, orphaned, boarding school, and non-perinatally infected children as well (22, 31, 51). Some research programs in progress have made steps in that direction (25, 27, 34, 45, 52); some have conducted research at community sites overcoming biases toward studying only treated populations and overcoming barriers to participation in research such as travel to health center research sites [e.g., Ref. (22)].
Gather Data in a Way That Enhances Systematic Review or Cross-Study Comparisons
Data standards, such as CONSORT,3 recommend collection of summary statistics and their precision. That is, statistics ought be reported with accompanying measures of variability; many times, mean age at disclosure was reported without a measure of variability such as the SD; sometimes only frequencies of varying age ranges were reported (e.g., ages 5–9, 10–12, etc.) from which the current authors may or may not have been able to calculate a summary measure such as the median. Standards were often not met regardless of qualitative, quantitative, or mixed-method approaches.
Improve Description with More Precise Measures
Articles differed in the precision with which variables were described, e.g., some articles excluded from the current summary did not specify whether the age of the child at the time of disclosure or age at time of interview about disclosure were being discussed. In describing who disclosed, some articles indicated “caregivers” or “health-care personnel,” while others specified the precise relationship of the discloser to the child (e.g., grandfather) or the exact role of the health-care provider (e.g., nurse, infectious disease doctor). Some indicated who was present when a number of individuals participated in disclosing (e.g., multiple people, suggesting some caregivers rely on the simultaneous support of health-care providers and other family members). The greater the precision, the easier it is to make cross-study comparisons and summaries. Further, the literature indicates that health personnel in differing roles may have differing attitudes (34, 53) and that caregivers in differing relationships may have differing issues about HIV disclosure (3, 15). Doctors appear to be greater advocates of early disclosure; HIV+ parents and grandparents may be involved in disclosing their own and relatives’ HIV along with the HIV status of the child (4).
No article asked the caregivers to reflect in a systematic way (e.g., Likert scales, paired comparison) on what experiences or what rationales were most influential in making the disclosure decision. Only one article (29) tried to eliminate the social desirability reporting bias that comes with face-to-face interviews or questionnaires handed directly to study personnel. New techniques, used with low literacy populations, may help reduce such biases by using voice recordings of questionnaires/interviews with study personnel available for assistance.
Improve Prediction with Longitudinal Data and Child Well-being Outcome Measures
By definition, the articles summarized here dealt with reflection on past behavior and thus were subject to biases of memory. Most studies relied on caregivers’ recall about date of disclosure, child reactions, and who may have been present. In fact, sometimes HIV+ children’s and caregivers’ accounts did not agree (14, 26, 35). Further, although a rationale may be thought to be influential, until research occurs pre- to post-disclosure, its influence cannot be verified. For example, Jemmott et al. (54), in research on intention to disclose found multiple reasons endorsed, but only normative beliefs – the perception that friends, relatives, and others important to the caregiver would want them to tell the child – and self-efficacy – belief they can tell the child – were significant predictors in a multiple regression of the intention to disclose. Further, it is as yet unknown, whether “telling” under certain circumstances or for certain reasons is more or less beneficial for the HIV+ child in physical and mental health domains and in social adjustment.
Longitudinal analysis about illnesses can be exacting (48): over time individuals get better with treatment or decline, older age brings new challenges such as older youth being more involved in maintaining their own treatment, caregiver–child relationships change with time, health-care settings, and personnel change with time. Disclosure unfolds alongside these processes. Documentation over time would inform interventions that could meet time- and maturation-dependent challenges.
Transition to Evaluation of Interventions
As suggested by multiple authors (14, 18, 27, 30), the research question no longer seems to be whether or not to fully disclose to children, but when and how. Several promising interventions have been designed or piloted (9, 15, 55, 56), with their common elements described below under clinical recommendations. Nearly all carry with them advice to be age- and context-sensitive.
Measure and Report Context at the Individual, Family, Community, Institutional, and National Levels
In largely quantitative articles, however, context is rarely described beyond a few characteristics of the affected children, their caregivers, several attributes of the family situation (e.g., child being raised by relatives, or an HIV+ parent) or where disclosure took place (e.g., home or clinic setting). The articles, providing background for this review, that do describe context – sometimes in case studies, policy papers or research on allied topics such as adherence – are compelling. A few examples will suffice: dilemmas faced by a grandmother who had promised her deceased daughter to never reveal the daughter had died of AIDS, but now discovers the grandchild she is raising is HIV+ (57); disclosure occasioned in a rural district by the child having to travel alone to get care (34); the differing issues for child-headed households in post-genocide Rwanda (8); marginalized and at-risk child and youth populations in India such as street children and children pressed into sex trade (51); secrecy and collusion about illness and medicine-taking within families in a community with high stigmatization of HIV (5); cultural conflict when fathers are family decision-makers, but mothers manage health care and are being told to disclose (15); and the surprise an HIV+ child felt when told her HIV+ status by an apparently healthy HIV+ adult nurse because of the child’s assumptions about how HIV progresses (58). Again some research programs are beginning to assess not only caregiver and health-provider attitudes but attitudes and policies of surrounding communities and institutions such as health-care clinics, hospitals, churches, and schools (1, 7, 8, 52, 54, 59), leading to additional targets for intervention. Systematic reporting about issues at multiple levels will aid context-sensitive full disclosure.
Improve Understanding with Mixed Qualitative–Quantitative Research
Several studies summarized here reported comments by older children, caregivers, and health-care providers reflecting on disclosure experiences. Such qualitative data were illuminating. For example, several disclosures were initiated because children did not understand why they had to keep taking medicines if their symptoms had disappeared (28, 34). Importantly, some researches documented that children who had not been told, already knew or suspected their diagnosis (35), or children who supposedly knew had not understood the disclosure fully (26, 40). Children in one study reported having questions post-disclosure while caregivers were unaware of their questions (39). Qualitative data, especially from the viewpoint of the children whose well-being is being fostered, can anticipate and correct likely misunderstandings.
Abrupt, delayed, or inadvertent disclosure has been described as harmful (15), while full disclosure has been cited as helpful to HIV+ children (18). As described in Sections “Common Elements in Interventions for Full Disclosure,” “Expand Training before Full Disclosure,” “Expand Support during Full Disclosure,” and “Expand Support after Full Disclosure” interventions are being developed to assist caregivers and children before, during, and after full disclosure so that the potential health benefits of full disclosure can be realized, and potential negative effects anticipated and ameliorated.
Recommended Age for Disclosure
While caregivers’ attitudes and beliefs about the best age for disclosure vary widely, systematic guidelines recommend age-appropriate disclosure to school-age children (18). While caregivers hold understandable concerns about potential negative consequences for children of early school age, objective information about children’s short-term reactions such as shock and fear and about long-term benefits such as improved adherence to health regimens may mitigate these worries and provide the impetus for full disclosure. Health-care providers also may often be unaware of best practices in terms of child age; for example, they may lack knowledge of how to use age-appropriate language during full disclosure (9, 15, 55, 56).
Common Elements in Interventions for Full Disclosure
Several systematic disclosure interventions have been designed or piloted (9, 15, 55, 56). They have the following common elements: (1) train health-care providers to assist with disclosure, (2) elicit caregiver concerns regarding disclosure, (3) assess child and caregiver readiness for full disclosure, (4) improve readiness by addressing concerns and rehearsing communications to child, (5) disclose with requested assistance, and (6) follow-up with assessment. Generally, the interventions take place in a health-care setting.
Expand Training before Full Disclosure
Several articles have suggested the need for training before full disclosure for health personnel, for parents/caregivers, and for children (22, 23, 26–31, 33–35, 37–39). Commonly, pre-disclosure interventions suggest responding to triggers such as questions from the child in honest, age-appropriate ways: for example, explaining about germs and medicines with drawings, and analogies such as the body protecting itself with little soldiers and medicines to help the soldiers (56, 58). Suggestions for health personnel include the use of simple language – terms such as “positive” have a vernacular meaning – and educating caregivers about HIV (57).
However, it also seems to be the case that garnering the community support that will ultimately be needed ought to begin prior to full disclosure [e.g., Ref. (32)]. HIV+ children, ages 10–14, reflecting on their disclosure experiences, commented that safe persons (relatives and friends who knew and understood) and safe places (e.g., a church group) were particularly helpful to them in their adjustment to living with HIV after learning their diagnosis (50). But schools have often been described as not safe. At least one article suggests that few families disclose to school personnel but may need special school services for their HIV+ children (61). It seems reasonable that educative efforts should be extended to these ultimate sources of support, especially since the majority of children in the articles summarized here are in school, some in boarding school separated from family supports (22, 25, 27, 30, 33, 37).
Expand Support during Full Disclosure
Blasini et al. (55), in early work, stressed the importance of letting caregivers decide whether they wanted to disclose alone or with the assistance of health-care providers. Preferences in the articles summarized here seem to vary country to country and person to person, with some caregivers wishing to disclose alone, or with other relatives present, or with assistance from health-care providers, or with another complement of individuals (22, 30, 35). Some caregivers wished to defer and let health-care providers disclose directly to the child (7). Sometimes the caregiver decision was co-opted by the health-care system; disclosure occurred without caregiver input [e.g., Ref. (41, 43)]. In some cases, caregivers were actively discouraged from disclosing by health-care personnel (23, 34). Neither article explicated the health-care worker’s reasons for being discouraging, but one documented the caregivers’ strong perception of health personnel’s negative attitudes toward disclosure (34).
Older HIV+ youth reflecting on their earlier disclosure experiences may be an important source of decision-making. In at least one study (62), health-care workers encouraged disclosing alone at home, while youth preferred disclosure with health personnel and the caregiver in a health setting. Youth also often complained that their questions were not heard or answered; communication was directed to adults rather than to them (39). These two studies concern youth who had been told when they were older than early school age. It is likely that preferences might vary by context and child maturity.
Consensus guidelines on breaking bad news in the field of cancer suggest that disclosure should take place across several meetings including enough time to assess the patient’s understanding and emotional status, encourage expression of feelings and respond empathetically, arrange a time to review the situation, offer assistance telling others, and provide information about support services as well as discussing treatment (63, 64). Yet, some caregivers in the studies reviewed here believed disclosure should be a discreet event (31).
Expand Support after Full Disclosure
Several articles recommended continuing supports for both caregivers and children post-disclosure (13, 22, 28, 31). Peer groups would assist both caregivers and children to adjust to HIV post-disclosure as would continuing education about HIV and its treatment. Caregivers may need support concerning caregiver–child communication, including appropriate language to use with children, how to explore local cultural factors influencing adjustment to illness, and how to deal with caregiver or child fears about the consequences of disclosure (16). Children may need resources to deal with stigmatizing experiences, to support their physical and mental health, and to aid their access to health care.
The emphasis on whether or not to disclose an HIV diagnosis to children, driving research since the early 1990s, has now shifted to when and how children should be told. Recent evidence suggests that caregivers may want to tell an HIV+ child that the child has HIV, but may fear negative consequences for their families and children. To alleviate their concerns, more support may be necessary prior to, during, and after disclosure. The nature of this support should include the voices of older HIV+ youth aware of their diagnoses, caregivers, health-care providers, and those knowledgeable about local context. To address stigma, support may require changes in institutional policies to address stigmatizing behaviors, encourage physical/mental health, and foster social acceptance in the communities where HIV+ children live. To promote child well-being across the local, institutional, and national contexts that HIV+ children face, future research should aim toward developing “best practice” child-sensitive and context-sensitive standards of HIV disclosure for caregivers and health-care providers.
BK and SL made substantial contributions to the conception, design, acquisition of articles, analysis, and interpretation of data for this review. BK and SL had been part of the team that drafted the WHO guideline for disclosure to children 12 and under (18), looking at literature through June 2010 on outcomes for children who had and had not been disclosed to. CO made substantial conceptual and interpretive contributions. For her Capstone Paper in fulfillment of a Master’s Degree in Urban Public Health at City University of New York School of Public Health, Spring 2011, CO focused on the reasons caregivers gave for disclosure within an expanded HIV disclosure literature. The current review updates literature from January 1996 through December 2015 concentrating on caregiver reasons for disclosing and not disclosing to HIV+ children 12 and under. All authors have read, revised, and approved the manuscript, and are accountable for the accuracy of its content.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors would like to thank Anniek De Baets (Department of Pediatrics, University of Antwerp), Julie Murugi (Consultant, WHO), and F. Amolo Okero (HIV Department, WHO), all members of the WHO guideline authorship team. The example of in-depth analysis provided by the authorship team and the WHO guideline group informed our current recommendations. We gratefully acknowledge the expertise of two librarians, John Carey (Hunter College, USA) and Julie Murugi, who participated in the research article search for the WHO guideline. They taught us valuable lessons about global searches and acquisition of articles. Likewise, the diligence of research assistants, Jamille McLawrence and Esther Muslumova (Hunter College), provided many of the hard copies of articles through June 2010. Our thanks also go to Lydia Isaac, Ph.D. (formerly at Hunter College, now at George Washington University, USA), who jointly supervised CO’s Capstone paper with BK.
1. Bandason T, Langhaug LF, Makamba M, Laver S, Hatzold K, Mahere S, et al. Burden of HIV among primary school children and feasibility of primary school-linked HIV testing in Harare, Zimbabwe: a mixed methods study. AIDS Care (2013) 25(12):1520–6. doi:10.1080/09540121.2013.780120
2. Cruz MLS, Bastos FI, Darmont M, Dickstein P, Monteiro S. The “moral career” of perinatally HIV-infected children: revisiting Goffman’s concept. AIDS Care (2015) 27(1):6–9. doi:10.1080/09540121.2014.940270
3. Galano E, De Marco MA, Succi RC, Silva MH, Machado DM. [Interviews with family members: a fundamental tool for planning the disclosure of a diagnosis of HIV/aids for children and adolescents]. Ciên Saúde Colet (2012) 17(10):2739–48. doi:10.1590/S1413-81232012001000022
4. Gachanja G, Burkholder GJ, Ferraro A. HIV-positive parents, HIV-positive children, and HIV-negative children’s perspectives on disclosure of a parent’s and child’s illness in Kenya. PeerJ (2014) 2:e486. doi:10.7717/peerj.486
6. Ishikawa N, Pridmore P, Carr-Hill R, Chaimuangdee K. Breaking down the wall of silence around children affected by AIDS in Thailand to support their psychosocial health. AIDS Care (2010) 22(3):308–13. doi:10.1080/09540120903193732
7. Biadgilign S, Deribew A, Amberbir A, Escudero HR, Deribe K. Factors associated with HIV/AIDS diagnostic disclosure to HIV infected children receiving HAART: a multi-center study in Addis Ababa, Ethiopia. PLoS One (2011) 6(3):e17572. doi:10.1371/journal.pone.0017572
8. Binagwaho A, Fuller A, Kerry V, Dougherty S, Agbonyitor M, Wagner C, et al. Adolescents and the right to health: eliminating age-related barriers to HIV/AIDS services in Rwanda. AIDS Care (2012) 24(7):936–42. doi:10.1080/09540121.2011.648159
9. Boon-Yasidhi V, Chokephaibulkit K, McConnell MS, Vanprapar N, Leowsrisook P, Prasitsurbsai W, et al. Development of a diagnosis disclosure model for perinatally HIV-infected children in Thailand. AIDS Care (2013) 25(6):756–62. doi:10.1080/09540121.2012.749331
11. Arage G, Tessema GA, Kassa H. Adherence to antiretroviral therapy and its associated factors among children at South Wollo Zone Hospitals, Northeast Ethiopia: a cross-sectional study. BMC Public Health (2014) 14(1):365. doi:10.1186/1471-2458-14-365
12. Haberer JE, Cook A, Walker S, Ngambi M, Ferrier A, Mulenga V, et al. Excellent adherence to antiretrovirals in HIV+ Zambian is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One (2011) 6(4):e18505. doi:10.1371/journal.pone.0018505
13. Polisset J, Ametonou F, Arrive E, Aho A, Perez F. Correlates of adherence to antiretroviral therapy in HIV-infected children in Lom, Togo, West Africa. AIDS Behav (2009) 13(1):23–32. doi:10.1007/s10461-008-9437-6
14. Vreeman RC, Gramelspacher AM, Gisore PO, Scanlon ML, Nyandiko WM. Disclosure of HIV status to children in resource-limited settings: a systematic review. J Int AIDS Soc (2013) 16:18466. doi:10.7448/IAS.16.1.18466
15. Beima-Sofie K, John-Stewart G, Shah B, Wamalwa D, Maleche-Obimbo E, Kelley M. Using health provider insights to inform pediatric HIV disclosure: a qualitative study and practice framework from Kenya. AIDS Patient Care STDS (2014) 28(10):555–64. doi:10.1089/apc.2014.0040
16. Santamaria EK, Dolezal C, Marhefka SL, Hoffman S, Ahmed Y, Elkington K, et al. Psychosocial implications of HIV serostatus disclosure to youth with perinatally acquired HIV. AIDS Patient Care STDS (2011) 25(4):257–64. doi:10.1089/apc.2010.0161
19. Joint United Nations Programme on HIV/AIDS (UNAIDS). Core Epidemiology Slides. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS) (2015). Available from: http://www.unaids.org/en/resources/documents/2015/20150714_coreepidemiologyslides_ppt
20. Sohn AH, Hazra R. The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents. J Int AIDS Soc (2013) 16:18555. doi:10.7448/IAS.16.1.18555
21. Bartlett JG. Ten years of HAART: principles for the future. Paper Presented in Plenary Session at: 13th Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5–8; Denver, Colorado (2006). Available from: http://www.medscape.org/viewarticle/523119
22. Abebe W, Teferra S. Disclosure of diagnosis by parents and caregivers to children infected with HIV: prevalence associated factors and perceived barriers in Addis Ababa, Ethiopia. AIDS Care (2012) 24(9):1097–102. doi:10.1080/09540121.2012.656565
23. Atwiine B, Kiwanuka J, Musinguzi N, Atwine D, Haberer JE. Understanding the role of age in HIV disclosure rates and patterns for HIV-infected children in southwestern Uganda. AIDS Care (2015) 27(4):424–30. doi:10.1080/09540121.2014.978735
24. Funck-Brentano I, Costagliola D, Seibel N, Straub E, Tardieu M, Blanche S. Patterns of disclosure and perceptions of the human immunodeficiency virus in infected elementary school-age children. Arch Pediatr Adolesc Med (1997) 151(10):978–85.
27. Brown BJ, Oladokun RE, Osinusi K, Ochigbo S, Adewole IF, Kanki P. Disclosure of HIV status to infected children in a Nigerian HIV care programme. AIDS Care (2011) 23(9):1053–8. doi:10.1080/09540121.2011.554523
28. Fetzer BC, Mupenda B, Lusiama J, Kitetele F, Golin C, Behets F. Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a Sub-Saharan setting: insights from a qualitative study. AIDS Patient Care STDS (2011) 25(10):611–21. doi:10.1089/apc.2011.0083
31. Kiwanuka J, Mulogo E, Haberer JE. Caregiver perceptions and motivation for disclosing or concealing the diagnosis of HIV infection to children receiving HIV care in Mbarara, Uganda: a qualitative study. PLoS One (2014) 9(3):e93276. doi:10.1371/journal.pone.0093276
32. Lester P, Chesney M, Cooke M, Weiss R, Whalley P, Perez B, et al. When the time comes to talk about HIV: factors associated with diagnostic disclosure and emotional distress in HIV-infected children. J Acquir Immune Defic Syndr (2002) 31(3):309–17. doi:10.1097/00126334-200211010-00006
33. Mahloko JM, Madiba S. Disclosing HIV diagnosis to children in Odi district, South Africa: reasons for disclosure and non-disclosure. Afr J Prim Health Care Fam Med (2012) 2(1):7. doi:10.4102/phcfm.v4i1.34538
34. Mweemba M, Musheke MM, Michelo C, Halwiindi H, Mweemba O, Zulu JM. “When am I going to stop taking the drug?” Enablers, barriers and processes of disclosure of HIV status by caregivers to adolescents in a rural district in Zambia. BMC Public Health (2015) 15(1):1028. doi:10.1186/s12889-015-2372-3
36. Oberdorfer P, Puthanakit T, Louthrenoo O, Charnsil C, Sirisanthana V, Sirisanthana T. Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand. J Paediatr Child Health (2006) 42(5):283–8. doi:10.1111/j.1440-1754.2006.00855.x
37. Tadesse BT, Foster BA, Berhan Y. Cross sectional characterization of factors associated with pediatric HIV status disclosure in Southern Ethiopia. PLoS One (2015) 10(7):e0132691. doi:10.1371/journal.pone.0132691
38. Vaz L, Corneli A, Dulyx J, Rennie S, Omba S, Kitetele F, et al. The process of HIV status disclosure to HIV-positive youth in Kinshasa, Democratic Republic of the Congo. AIDS Care (2008) 20(7):842–52. doi:10.1080/09540120701742276
39. Vaz LME, Eng E, Maman S, Tshikandu T, Behets F. Telling children they have HIV: lessons learned from findings of a qualitative study in sub-Saharan Africa. AIDS Patient Care STDS (2010) 24(4):247–56. doi:10.1089/apc.2009.0217
40. Vreeman RC, Scanlon ML, Marete I, Mwangi A, Inui TS, McAteer CI, et al. Characteristics of HIV-infected adolescents enrolled in a disclosure intervention trial in western Kenya. AIDS Care (2015) 27:6–17. doi:10.1080/09540121.2015.1026307
42. Corneli A, Vaz L, Dulyx J, Omba S, Rennie S, Behets F. The role of disclosure in relation to assent to participate in HIV-related research among HIV-infected youth: a formative study. J Int AIDS Soc (2009) 12:17. doi:10.1186/1758-2652-12-17
43. Mellins CA, Brackis-Cott E, Dolezal C, Richards A, Nicholas SW, Abrams EJ. Patterns of status disclosure to perinatally HIV-infected children and subsequent mental health outcomes. Clin Child Psychol Psychiatry (2002) 7(1):101–14. doi:10.1177/1359104502007001008
44. Zhao G, Zhao Q, Li X, Fang X, Zhao J, Zhang L. Family-based care and psychological problems of AIDS orphans: does it matter who was the care-giver? Psychol Health Med (2010) 15(3):326–35. doi:10.1080/13548501003623989
45. Heeren GA, Jemmott JB, Sidloyi L, Ngwane Z, Tyler JC. Disclosure of HIV diagnosis to HIV-infected children in South Africa: focus groups for intervention development. Vulnerable Child Youth Stud (2012) 7(1):47–54. doi:10.1080/17450128.2012.656733
46. Menon A, Glazebrook C, Campain N, Ngoma M. Mental health and disclosure of HIV status in Zambian adolescents with HIV infection: implications for peer-support programs. J Acquir Immune Defic Syndr (2007) 46(3):349–54. doi:10.1097/QAI.0b013e3181565df0
48. Butler AM, Williams PL, Howland DS, Hutton N, Seage GR. Impact of disclosure of HIV infection on health-related quality of life among children and adolescent with HIV infection. Pediatrics (2009) 123(3):935–43. doi:10.1542/peds.2008-1290
49. Mutumba M, Musiime V, Tsai AC, Byaruhanga J, Kiweewa F, Bauermeister JA, et al. Disclosure of HIV status to perinatally infected adolescents in urban Uganda: a qualitative study on timing, process, and outcomes. J Assoc Nurses AIDS Care (2015) 26(4):472–84. doi:10.1016/j.jana.2015.02.001
50. Phuma-Ngaiyaye EE, Dartey AF. Experiences of children living with HIV and AIDS following their diagnosis disclosure in Mzuzu, Malawi. Vulnerable Child Youth Stud (2015) 10(4):357–65. doi:10.1080/17450128.2015.1083639
52. Vreeman RC, Scanlon ML, Mwangi A, Turissini M, Ayaya SO, Tenge C, et al. A cross-sectional study of disclosure of HIV status to children and adolescents in Western Kenya. PLoS One (2014) 9(1):e86616. doi:10.1371/journal.pone.0086616
53. Watermeyer J. ‘Are we allowed to disclose?’: a healthcare team’s experiences of talking with children and adolescents about their HIV status. Health Expect (2015) 18(4):590–600. doi:10.1111/hex.12141
54. Jemmott J, Heeren G, Sidloyi L, Marange C, Tyler J, Ngwane Z. Caregivers’ intentions to disclose HIV diagnosis to children living with HIV in South Africa: a theory-based approach. AIDS Behav (2014) 18(6):1027–36. doi:10.1007/s10461-013-0672-0
55. Blasini I, Chantry C, Cruz C, Ortiz L, Salabarria I, Scalley N, et al. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr (2004) 25(3):181–9. doi:10.1097/00004703-200406000-00007
56. Trejos AM, Reyes L, Bahamon MJ, Alarcón Y, Gaviria G. [Effects in the adherence treatment and psychological adjustment after the disclosure of HIV/AIDS diagnosis with the “DIRE” clinical model in Colombian children under 17]. Rev Chilena De Infectol (2015) 32(4):408–15. doi:10.4067/S0716-10182015000500007
58. Nzota MS, Matovu JKB, Draper HR, Kisa R, Kiwanuka SN. Determinants and processes of HIV status disclosure to HIV-infected children aged 4 to 17 years receiving HIV care services at Baylor College of Medicine Children’s Foundation Tanzania, Centre of Excellence (COE) in Mbeya: a cross-sectional study. BMC Pediatr (2015) 15:81. doi:10.1186/s12887-015-0399-3
59. Mburu G, Ram M, Oxenham D, Haamujompa C, Iorpenda K, Ferguson L. Responding to adolescents living with HIV in Zambia: a social-ecological approach. Child Youth Serv Rev (2014) 45:9–17. doi:10.1016/j.childyouth.2014.03.033
60. Petersen I, Bhana A, Myeza N, Alicea S, John S, Holst H, et al. Psychosocial challenges and protective influences for socio-emotional coping of HIV+ adolescents in South Africa: a qualitative investigation. AIDS Care (2010) 22(8):970–8. doi:10.1080/09540121003623693
61. Mialky E, Vagnoni J, Rutstein R. School-age children with perinatally acquired HIV infection: medical and psychosocial issues in a Philadelphia cohort. AIDS Patient Care STDS (2001) 15(11):575–9. doi:10.1089/108729101753287667
62. Kidia KK, Mupambireyi Z, Cluver L, Ndhlovu CE, Borok M, Ferrand RA. HIV status disclosure to perinatally-infected adolescents in Zimbabwe: a qualitative study of adolescent and healthcare worker perspectives. PLoS One (2014) 9(1):e87322. doi:10.1371/journal.pone.0087322
Keywords: HIV, disclosure, stigma, children, global review
Citation: Krauss BJ, Letteney S and Okoro CN (2016) Why Tell Children: A Synthesis of the Global Literature on Reasons for Disclosing or Not Disclosing an HIV Diagnosis to Children 12 and under. Front. Public Health 4:181. doi: 10.3389/fpubh.2016.00181
Received: 29 March 2016; Accepted: 15 August 2016;
Published: 08 September 2016
Edited by:Grace Gachanja, Walden University, USA
Reviewed by:Gerjo Kok, Maastricht University, Netherlands
Silvia Carlos, University of Navarra, Spain
Anna Helova, University of Alabama at Birmingham, USA
Copyright: © 2016 Krauss, Letteney and Okoro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Beatrice J. Krauss, email@example.com